Article Text

PDF
P35 Histiocytoid cardiomyopathy and microphthalmia with linear skin defects syndrome: Phenotypes linked by truncating variants in NDUFB11
  1. Gillian Rea1,2,
  2. James S Ware1,2,
  3. Tessa Homfray3,
  4. Jan Till3,
  5. Ferran Roses-Noguer3,
  6. Rachel Buchan1,2,
  7. Sam Wilkinson1,2,
  8. Alicja Wilk1,2,
  9. Roddy Walsh1,2,
  10. Shibu John1,2,
  11. Shane McKee4,
  12. Fiona J Stewart4,
  13. Victoria Murday5,
  14. Robert W Taylor6,
  15. A John Baksi3,
  16. Piers Daubeney3,
  17. Sanjay Prasad1,3,
  18. Paul JR Barton1,2,
  19. Stuart A Cook1,2,7
  1. 1NIHR Cardiovascular Biomedical Research Unit at Royal Brompton & Harefield NHS Foundation Trust and Imperial College London, London SW3 6NP, UK
  2. 2National Heart & Lung Institute, Imperial College London, London SW3 6NP, UK
  3. 3Royal Brompton & Harefield NHS Foundation Trust, Sydney St, London SW3 6NP, UK
  4. 4Department OfClinical Genetics, Belfast City Hospital, Belfast, BT9 7AB, UK
  5. 5Department OfClinical Genetics, Laboratory Medicine, The Queen Elizabeth University Hospital, Glasgow, G51 4TF, UK
  6. 6Wellcome Trust Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle Upon Tyne, NE2 4HH, UK
  7. 7National Heart Centre Singapore, Singapore 169609, Singapore

Abstract

Mutations in NDUFB11, which encodes a component of the Mitochondrial Respiratory Chain (MRC) were recently reported to cause both Histiocytoid Cardiomyopathy (Histiocytoid CM) and Microphthalmia with Linear Skin Defects Syndrome (MLS syndrome). Histiocytoid CM is a rare, distinctive form of cardiomyopathy with ˜ 150 cases reported worldwide, that predominantly affects females early in life and is characterised by arrhythmias and associated sudden death. MLS syndrome, also known as a MIDAS (microphthalmia, dermal aplasia, and sclerocornea) syndrome, is a rare X-linked disorder with male lethality in utero, characterised by unilateral or bilateral microphthalmia and linear skin defects, along Blaschko lines, which are classically limited to the face and neck, present from birth, and heal with time, often leaving minimal scarring. Here we report a fourth case of Histiocytoid CM with a de novo nonsense mutation in NDUFB11 (ENST00000276062.8: c.262C >T;p. Arg88Ter), identified using Whole Exome Sequencing (WES) of a family trio. An identical mutation has been previously reported in association with MLS syndrome. Our case lacked the diagnostic features of MLS syndrome but detailed clinical comparison of the two cases revealed significant phenotypic overlap. Heterozygous mutations in HCCS and COX7B, which, like NDUFB1, encode proteins of the MRC, have also previously been identified in MLS syndrome including a case with features of both MLS syndrome and Histiocytoid CM. However, a systematic review of WES data from previously published Histiocytoid CM cases, alongside four additional cases presented here for the first time, did not identify any mutations in these genes. We conclude that that NDUFB11 is a cause of both Histiocytoid CM and MLS, and that these disorders are allelic (genetically related). Screening for evidence of malignant arrhythmias and cardiomyopathy would be appropriate in individuals with MLS syndrome.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.